Tokyo, Japan and London, UK, 27 February 2023 – Sosei Group Corporation (“the Company”; TSE: 4565) announces that it will hold two events to provide individual investors the opportunity to meet with senior management. The meetings will take place on 24 March 2023 in the cities of Nagoya and Osaka, Japan.

Chris Cargill, CEO, Matt Barnes, President of Heptares Therapeutics and Head of UK R&D, along with Hironoshin Nomura, CFO will present an update on the Company’s pipeline and business strategy at these meetings.  

For investors who wish to attend the events, please apply by registering your details at one of the URL links below. A participation voucher will be delivered via email following successful completion of your application. 

Osaka Meeting

• Date:     Friday 24 March 2023
• Time:    10:30am – 11:30am JST (Reception starts at 10:15am)
• Venue:   Osaka Umeda Twin Towers North, 26th Floor, Room 1,2,3　
• Address: 8-1 Kakuda-cho, Kita-ku, Osaka (Map)
• Attendee registration link (Japanese only):  Please click here

*Please note this event is limited to 100 participants, and invitation vouchers will be allocated on a first-come-first-served basis.

Nagoya Meeting

• Date:   Friday 24 March 2023 
• Time:   3:00pm – 4:00pm JST (Reception starts at 2:45pm)
• Venue: Midland Hall
• Address: 4-7-1. Meieki, Nakamura-ku, Nagoya (Map)
• Attendee registration link (Japanese only): Please click here  

*Please note this event is limited to 60 participants, and invitation vouchers will be allocated on a first-come-first-served basis.

-ENDS-